Yabao Pharmaceutical Group Co., Ltd (SHA:600351)
6.20
+0.15 (2.48%)
Jul 3, 2026, 3:00 PM CST
Yabao Pharmaceutical Group Company Description
Yabao Pharmaceutical Group Co., Ltd engages in the research and development, production, and sale of pharmaceutical products in China and internationally.
It provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, analgesics, psychotropic drugs, women's health products, patches, and general health products.
The company was founded in 1978 and is based in Beijing, China.
Yabao Pharmaceutical Group Co., Ltd
| Country | China |
| Founded | 1978 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 3,415 |
| CEO | Wei Ren |
Contact Details
Address: Building 2 Beijing, 100176 China | |
| Phone | 86 40 0167 8200 |
| Website | yabao.com.cn |
Stock Details
| Ticker Symbol | 600351 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE000001CM5 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Wei Ren | GM and Vice Chairman |
| Zhe Feng Zuo | Chief Financial Officer and Accounting Supervisor |
| Pengbo Ren | Deputy GM, Secretary of the Board of Directors and Director |
| Jun Liang | Deputy General Manager |
| Ke Tang | Deputy General Manager |
| Li He | Deputy General Manager |